Regeneron Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030

Updated on 03/29/2024

Stock Rating
2
Price Target
$1.05k
Consensus
Outperform
Upside
8.87%
Analysts
8
Stock Rating
2
Upside
8.87%
Analysts
8
Price Target
$1.05k

Regeneron Pharmaceuticals Stock Forecast and Price Target

The average target price for Regeneron Pharmaceuticals's stock set by eight renowned analysts in recent months is $1050.00, representing a potential upside of approximately 8.87% from its last closing price if met by 2025. This estimation is based on a high estimate of $1184.00 and a low estimate of $710.00. If you want to invest in REGN stock, you might also want to take a look at how its competitors are doing.

$1.05k

8.87% Upside

Outperform
Outperform

Regeneron Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Regeneron Pharmaceuticals's Price has seen a drop from $490.30 to $0.00 – a 100.00% decrease. Analysts predict that Regeneron Pharmaceuticals's Fair Value will increase in the upcoming year, reaching $743.01. This would represent an increase of 100.00%. Over the next seven years, experts predict that Regeneron Pharmaceuticals's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$743.01
2025 Fair Value Forecast
$741.45
2026 Fair Value Forecast
$724.94
2027 Fair Value Forecast
$688.48
2028 Fair Value Forecast
$650.78
2029 Fair Value Forecast
$637.38
2030 Fair Value Forecast
$627.41
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABBV Stock Forecast AbbVie Outperform 9
$179.63 Buy/Sell $178.42 0.21%
CMCSA Stock Forecast Comcast Corp Outperform 10
$43.54 Buy/Sell $50.29 16.49%
VZ Stock Forecast Verizon Communications Outperform 6
$40.13 Buy/Sell $45.10 14.00%
PFE Stock Forecast Pfizer Outperform 2
$28.37 Buy/Sell $32.87 10.82%
AMGN Stock Forecast Amgen Outperform 4
$275.36 Buy/Sell $303.65 14.40%

Regeneron Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Regeneron Pharmaceuticals's Revenue has seen an increase, rising from $8.31B to $13.12B. This represents a growth of 57.84%. According to 16 major analysts, Regeneron Pharmaceuticals's Revenue will fall by 2.04% in the next year, reaching $12.85B. Professionals believe that By 2030, Regeneron Pharmaceuticals's Revenue will fall to $11.25B– a 14.21% decrease from its current value.

2024 Rev Forecast
$12.85B
2025 Rev Forecast
$12.88B
2026 Rev Forecast
$12.82B
2027 Rev Forecast
$11.97B
2028 Rev Forecast
$11.70B
2029 Rev Forecast
$11.62B
2030 Rev Forecast
$11.25B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BMY Stock Forecast Bristol-Myers Squibb Hold 2
$54.36 Buy/Sell $58.15 1.18%
GILD Stock Forecast Gilead Sciences Inc Outperform 11
$75.32 Buy/Sell $87.82 10.20%
4519 Stock Forecast Chugai Pharmaceutical Outperform 6
¥6.51k Buy/Sell ¥4.92k -5.57%

Regeneron Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
2914 Stock Forecast Japan Tobacco Outperform 6
¥3.82k Buy/Sell ¥3.25k 1.99%
4502 Stock Forecast Takeda Pharmaceutical Company Outperform 5
¥4.31k Buy/Sell ¥4.74k 6.63%
ALC Stock Forecast Alcon Outperform 8
CHF77.20 Buy/Sell CHF90.64 24.62%

Regeneron Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$5.63B
2025 FCF Forecast
$5.70B
2026 FCF Forecast
$5.50B
2027 FCF Forecast
$5.38B
2028 FCF Forecast
$5.38B
2029 FCF Forecast
$5.26B
2030 FCF Forecast
$5.17B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BIIB Stock Forecast Biogen Outperform 10
$230.07 Buy/Sell $299.62 29.09%
CE Stock Forecast Celanese Hold 13
$157.43 Buy/Sell $148.23 1.63%
BGNE Stock Forecast BeiGene Buy 6
$164.53 Buy/Sell $285.19 67.14%

Regeneron Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

Regeneron Pharmaceuticals's EBITDA has grown in the last three years, jumping from $3.53B to $4.65B – an increase of 31.82%. In the next year, analysts predict that EBITDA will reach $7.12B – an increase of 52.92%. For the next seven years, the forecast is for EBITDA to grow by 28.17%.

2024 EBITDA Forecast
$7.12B
2025 EBITDA Forecast
$6.93B
2026 EBITDA Forecast
$6.98B
2027 EBITDA Forecast
$5.47B
2028 EBITDA Forecast
$5.62B
2029 EBITDA Forecast
$5.79B
2030 EBITDA Forecast
$5.97B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
INCY Stock Forecast Incyte Outperform 9
$60.79 Buy/Sell $77.05 26.99%
UTHR Stock Forecast United Therapeutics Outperform 12
$249.51 Buy/Sell $284.08 19.63%
JAZZ Stock Forecast Jazz Pharmaceuticals Outperform 14
$116.63 Buy/Sell $188.32 59.52%

Regeneron Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Regeneron Pharmaceuticals's EBIT has increased by 28.48%, going from $3.29B to $4.23B. In the next year, analysts are expecting an increase in EBIT, predicting it will reach $5.27B – an increase of 24.39%. The Regeneron Pharmaceuticals forecast is for EBIT to reach $4.43B or grow by 4.55%.

2024 EBIT Forecast
$5.27B
2025 EBIT Forecast
$5.62B
2026 EBIT Forecast
$6.90B
2027 EBIT Forecast
$6.84B
2028 EBIT Forecast
$4.67B
2029 EBIT Forecast
$4.27B
2030 EBIT Forecast
$4.43B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
IONS Stock Forecast Ionis Pharmaceuticals Outperform 9
$43.26 Buy/Sell $55.60 41.01%
EXEL Stock Forecast Exelixis Outperform 16
$22.46 Buy/Sell $26.44 20.21%
SPIE Stock Forecast SPIE Outperform 18
33.82€ Buy/Sell 32.33€ 10.88%

Regeneron Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Regeneron Pharmaceuticals's EPS has seen a drop from $31.47 to $0.00 – a 100.00% decrease. Analysts predict that Regeneron Pharmaceuticals's EPS will increase in the upcoming year, reaching $47.69. This would represent an increase of 100.00%. Over the next seven years, experts predict that Regeneron Pharmaceuticals's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$47.69
2025 EPS Forecast
$47.59
2026 EPS Forecast
$46.53
2027 EPS Forecast
$44.19
2028 EPS Forecast
$41.77
2029 EPS Forecast
$40.91
2030 EPS Forecast
$40.27
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BHC Stock Forecast Bausch Health Companies Hold 15
$9.12 Buy/Sell $9.50 -1.32%
MRUS Stock Forecast Merus N.V. Buy 6
$47.72 Buy/Sell $43.70 20.49%
GLPG Stock Forecast Galapagos NV Hold 6
31.94€ Buy/Sell 39.85€ 13.49%